|

zamtocabtagene autoleucel Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Miltenyi Biomedicine GmbH1

Indications

  • Diffuse Cutaneous Systemic Sclerosis1
  • Lupus Nephritis1
  • Systemic Lupus Erythematosus1
  • Systemic Sclerosis (SSc)1
  • Lupus1

Milwaukee, Wisconsin1 trial

US Zamto-cel Autoimmune Diseases

Froedtert Hospital and the Medical College of Wisconsin

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.